Eisai
4523.T
#2194
Rank
NZ$14.57 B
Marketcap
NZ$51.66
Share price
1.58%
Change (1 day)
9.21%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): NZ$1.42

According to Eisai's latest financial reports the company's current EPS (TTM) is NZ$1.49. an increase over its 2024 EPS that were of NZ$1.68.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2025NZ$1.8811.85%
2024NZ$1.68-32.63%
2023NZ$2.495.52%
2022NZ$2.36-74.01%
2021NZ$9.08-66.58%
2020NZ$27.1698.24%
2019NZ$13.7017.01%
2018NZ$11.7137.78%
2017NZ$8.50-27.62%
2016NZ$11.7435.33%
2015NZ$8.68-2.82%
2014NZ$8.93-27.66%
2013NZ$12.34-27.49%
2012NZ$17.02-12.67%
2011NZ$19.4988.08%
2010NZ$10.37-11.06%
2009NZ$11.65-390.15%
2008NZ-$4.02-127.78%
2007NZ$14.4611.78%
2006NZ$12.944.38%
2005NZ$12.397.4%
2004NZ$11.5443.03%
2003NZ$8.0725.09%
2002NZ$6.4552.67%
2001NZ$4.2369.76%
2000NZ$2.49